At meeting held on 12 May 2015
Sun Pharma Advanced Research Company announced that the Board of Directors of the Company at its meeting held on 12 May 2015, authorized the further issuance of equity shares of Re. 1 each of the Company, on rights basis to the shareholders of the Company on such ratio and at such price and premium as may be decided in consultation with the Lead Managers to the proposed rights issue, so that the funds raised by way of right issue of shares is not more than Rs. 250 crores.The ratio of rights share entitlements, the issue price and the record date for fixing the entitlement of shareholders to such rights issue shall be informed in due course when decided.
Powered by Capital Market - Live News